MISSIONPHARMA GROUP ApS Financials, key figures and credit report
Gross profit - 110.0 kDKK FY 2022 -115.7% vs 2021
EBIT - 110.0 kDKK FY 2022 -115.7% vs 2021
Net debt 7 646.0 kDKK FY 2022 +26.1% vs 2021
Quick ratio 1.6 FY 2022 +0.3 vs 2021
Income statement (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -60.00 | -51.00 | -66.00 | -51.00 | - 110.00 |
| Gross profit | -60.00 | -51.00 | -66.00 | -51.00 | - 110.00 |
| EBIT | -60.00 | -51.00 | -66.00 | -51.00 | - 110.00 |
| Other financial income | 1.00 | 10.00 | |||
| Other financial expenses | -30.00 | 20.00 | -12.00 | -34.00 | -1.00 |
| Net income from associates (fin.) | 32 976.00 | 16 937.00 | 78 148.00 | 52 509.00 | 118 203.00 |
| Pre-tax profit | 32 886.00 | 18 866.00 | 78 070.00 | 52 425.00 | 118 102.00 |
| Income taxes | 20.00 | 1.00 | -29.00 | - 113.00 | 37.00 |
| Net earnings | 32 906.00 | 18 867.00 | 78 041.00 | 52 312.00 | 118 139.00 |
Assets (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 297 092.00 | 285 067.00 | 346 282.00 | ||
| Participating interests | 321 233.00 | 345 284.00 | |||
| Other non-current investments | -22 337.00 | ||||
| Investments total | 274 755.00 | 285 067.00 | 346 282.00 | 321 233.00 | 345 284.00 |
| Non-current loans receivable | 22 337.00 | ||||
| Long term receivables total | 22 337.00 | ||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 229.00 | ||||
| Current deferred tax assets | 5 077.00 | 4 033.00 | 7 816.00 | 12 193.00 | |
| Short term receivables total | 5 077.00 | 4 033.00 | 229.00 | 7 816.00 | 12 193.00 |
| Cash and bank deposits | 4 795.00 | 294.00 | 2 427.00 | 5.00 | |
| Cash and cash equivalents | 4 795.00 | 294.00 | 2 427.00 | 5.00 | |
| Balance sheet total (assets) | 306 964.00 | 289 394.00 | 348 938.00 | 329 049.00 | 357 482.00 |
Equity and liabilities (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 26 300.00 | 13 500.00 | 78 000.00 | 90 000.00 | 150 000.00 |
| Other reserves | 94 560.00 | 82 798.00 | 144 022.00 | - 203 961.00 | - 203 897.00 |
| Other restricted equity | 322 934.00 | 349 722.00 | |||
| Retained earnings | 142 966.00 | 169 472.00 | 47 992.00 | 61 524.00 | -64 367.00 |
| Profit of the financial year | 32 906.00 | 18 867.00 | 78 041.00 | 52 312.00 | 118 139.00 |
| Shareholders equity total | 296 857.00 | 284 762.00 | 348 180.00 | 322 934.00 | 349 722.00 |
| Provisions | - 197.00 | ||||
| Non-current other liabilities | 197.00 | ||||
| Non-current liabilities total | 197.00 | ||||
| Current trade creditors | 75.00 | ||||
| Current owed to group member | 10 046.00 | 4 582.00 | 33.00 | 6 064.00 | 7 651.00 |
| Short-term deferred tax liabilities | 665.00 | ||||
| Other non-interest bearing current liabilities | 61.00 | 50.00 | 60.00 | 51.00 | 34.00 |
| Current liabilities total | 10 107.00 | 4 632.00 | 758.00 | 6 115.00 | 7 760.00 |
| Balance sheet total (liabilities) | 306 964.00 | 289 394.00 | 348 938.00 | 329 049.00 | 357 482.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 The current price above includes VAT and is paid securely through Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated